NCT00751062

A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within Scandinavia

A 6-month, Randomized, Double-masked Comparison of PhXA41 With Timolol in Patients With Open Angle Glaucoma or Ocular Hypertension. A Multi-centre Study in Scandinavia

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 267 (actual)
• Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
• Sex: All
• Age: 40 Years
• Healthy volunteers: Not accepted

Summary

PhXA41 is not inferior to timolol in reducing intra-ocular pressure

Conditions

• Open Angle Glaucoma
• Ocular Hypertension

Interventions

Type	Name	Description
DRUG	timolol	One drop in the affected eye every morning from the morning bottle and one drop every evening from the evening bottle.
DRUG	PhXA41	One drop in the affected eye every morning from the morning bottle and one drop every evening from the evening bottle

Timeline

• Start date: 1992-11-01
• Primary completion: 1993-12-01
• Completion: 1993-12-01
• First posted: 2008-09-11
• Last updated: 2021-02-02

Locations

13 sites across 4 countries: Denmark, Finland, Norway, Sweden